US Newborn Screening Market Outlook 2020
|出版商||RNCOS E-Services Pvt. Ltd.||商品編碼||354792|
|出版日期||內容資訊||英文 40 Pages
美國現在，有93％的嬰兒為了檢驗某種疾病，接受嬰兒用檢查。聯邦政府和州政府也積極進行提高檢驗技術和檢驗普及等支援策略。最許多是血斑檢驗 (乾燥血斑檢驗)，接著依序為聽覺檢查，CCDH (先天性、重度的心臟病) 檢驗。嬰兒用篩檢有各種技術手段，尤其是免疫分析法最大量實施。嬰兒用檢查市場，今後由於政府的財政支援和認識度提高，技術進步等，一般認為將成長，不過統一規格、政策的缺乏，及醫院方面的實施體制的延遲，妨礙市場成長。
The US Newborn Screening market is set to witness several developments in near future. In the new report entitled, “US Newborn Screening Market Outlook 2020” the market has been separately studied under tests used for screening, and technologies supporting the diagnosis.
93% of the newborns are screened for various disorders under the newborn screening test in the US. The government is taking various measures to improve the quality and efficiency of these tests. Furthermore, the governments of various states are also engaged in expanding the panel of the tests.
Blood spot test is the most widely performed newborn screening test, followed by hearing screening and Critical Congenital Heart Disease (CCHD) Newborn Screening respectively. The screening technologies used for these tests include tandem mass spectrometry, immunoassays, pulse oximetry, DNA assays and electrophoresis. Immunoassay is the most extensively used technology for newborn screening. The large share of this technology is attributed to the fact that it is a part of primary screening tests for the newborn. Hence, these tests would always witness higher demand.
The report covers developments in the market occurring over the last two years, drivers and challenges controlling the market, and competitive landscape showing prominent players. Factors such as government support through funds, growing awareness, technological advancements and surging genetic disorders are fuelling the growth. On the other hand, lack of uniform regulatory policies in the country and delays in hospital administration are major hurdles of the market.
The study includes prudent analysis of the market size (tests and technologies) for 2014, and forecast till 2020. At the competitive forefront, research has been done at each player including their financials, key products, developments and SWOT analysis. In brief, study presented in the report is likely to generate interest among the potential investors.